TB-500

What Is TB-500?

TB-500 is a synthetic version of a specific seven-amino-acid segment found within Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid protein present throughout the body. That segment is known as the actin-binding motif, the part of the protein responsible for interacting with actin, a building-block protein that gives cells their shape and lets them move.

Researchers built TB-500 around this specific fragment after studies found that it retained meaningful activity from the full-length protein, making it a smaller, more practical tool for research than the complete 43-amino-acid molecule. While the fragment has been directly tested in several studies, the much larger body of Thymosin Beta-4 research, including its furthest-along human trials, has used the full-length protein rather than this shortened piece specifically.

What TB-500 Is Being Researched For

• Cell Migration and Tissue Repair

  The foundational research on this actin-binding fragment found it promoted dermal wound repair in diabetic and aged mice, conditions where healing is typically delayed, matching results seen with the full-length protein in the same study.^[1]

• Blood Vessel Formation

  Research isolating this same fragment found it was sufficient on its own to drive angiogenic activity, meaning the formation of new blood vessels, at a level comparable to the complete Thymosin Beta-4 protein in cell and tissue models.^[2]

• Wound Healing

  Broader foundational research on Thymosin Beta-4, the parent protein this fragment is drawn from, established its role in accelerating wound healing across multiple animal models, providing the research context this fragment was later tested against.^[3]

How TB-500 Works

• Interacting With Actin

  Research points to TB-500's core function coming from its ability to bind actin, temporarily holding it in a form that isn't yet built into the cell's structural framework. This actin-binding activity is what allows cells to reorganize quickly and move toward an area that needs repair.^[2]

• Driving Blood Vessel Formation

  Research points to this same actin-binding activity being what drives new blood vessel formation, since studies isolating just this fragment found it retained the angiogenic activity of the full-length protein, identifying it as the specific region responsible for that effect.^[2]

• Supporting Cell Movement During Healing

  Research points to this fragment promoting the kind of cell movement and reorganization needed for wound repair, with studies in diabetic and aged mice, both models of delayed healing, finding it accelerated repair in a way that matched the full-length protein's activity.^[1]

Reconstitution and Handling

TB-500 is typically supplied as a lyophilized powder in a sealed vial and reconstituted with bacteriostatic water before use in a research setting. Water should be added slowly rather than injected directly into the powder, and the vial should be swirled, not shaken.

Since the amount of water used affects the concentration of the final solution, researchers often use a dosage calculator to work this out before mixing. Once reconstituted, the solution is kept refrigerated to help preserve its stability.

Key Takeaways

TB-500 is built around the specific piece of Thymosin Beta-4 responsible for its actin-binding activity, and the research directly testing this fragment, rather than just the full-length protein, has found it retains meaningful activity in both wound repair and blood vessel formation models. That said, this fragment's own research base is considerably smaller than the parent protein's, and no human trial data exists for it specifically. Treat findings on the full-length protein as related context rather than direct evidence for this shortened version.

Frequently Asked Questions

Sources and Research

1. Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK. Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen. 2003;11(1):19-24.
2. Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK. The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J. 2003;17(14):2103-2105.
3. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368.